InsidersTradesSigma
Discover the full record of transactions filed by Ticho Barry, Directeur Médical. Director active across 1 companies, notably Stoke Therapeutics, Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €2.2m. The latest transaction was disclosed on 13 July 2021 — Cession. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Barry Ticho is the Chief Medical Officer at Stoke Therapeutics, Inc. He oversees the medical and clinical aspects of the company, ensuring compliance and innovation. His medical expertise is essential for the development of the company's products.